Skip to content
The Nexus
HEALTHMay 31 · 22:52 UTCNBC NEWS

Breakthrough pancreatic cancer treatment could double survival time

A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
daraxonrasibtopicpancreatic cancertopiclung cancertopicovarian cancertopiccolorectal cancertopicNBC NewsorganizationErika Edwardsperson
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting